[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$fwBzmfGlyTDE2KTu9eHEVAGQe51INJ1NMutKW9g8MSO4":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":157},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":46,"related":48},"differences-neisseria-gonorrhoeae-neisseria-meningitides","Differences between Neisseria gonorrhoeae and Neisseria meningitidis: A Complete Comparison","N. gonorrhoeae and N. meningitidis are both Gram-negative diplococci but differ fundamentally in capsule, diseases, transmission, maltose fermentation, serogroups, vaccine availability, and treatment. This complete comparison table covers all key distinguishing features for lab identification and clinical practice.",null,"Acharya Tankeshwar","2015-11-24","2026-07-04",false,"bacteriology","A microbiologist receives a culture plate from a genital specimen. On Modified Thayer-Martin agar, oxidase-positive Gram-negative diplococci have grown. The question is immediate: is this *Neisseria gonorrhoeae* — a sexually transmitted pathogen requiring contact tracing — or *Neisseria meningitidis*, which can occasionally colonise the genitourinary tract and must not be misidentified as gonorrhoea?\n\nThe single test that answers this question is **maltose fermentation**: *N. gonorrhoeae* ferments glucose only; *N. meningitidis* ferments both glucose and maltose. This one carbohydrate utilisation result separates the two most clinically important *Neisseria* species.\n\nDespite sharing morphology, cultural requirements, and oxidase-positive biochemistry, these two organisms cause fundamentally different diseases, occupy different body sites, and require completely different clinical responses. This article provides a systematic comparison of every key property that distinguishes them.\n\n*Neisseria gonorrhoeae* and *Neisseria meningitidis* are Gram-negative diplococci (kidney bean-shaped) with flattened sides.  They are characteristically found inside polymorphonuclear leucocytes. These are non-sporing, non-motile, and [oxidase](\u002Foxidase-test-principle-procedure-and-oxidase-positive-organisms\u002F) positive. They have exacting growth requirements and do not grow on ordinary media. Growth occurs on media enriched with blood or serum like Chocolate Agar, Thayer Martin Agar, and Modified New York City Medium.\n\nThe major structural difference between *N. meningitidis* (meningococci) and *N. gonorrhoeae* (gonococci) is the presence of a capsule. Meningococci have a thick polysaccharide capsule, whereas gonococci do not. In the laboratory, the differentiation between *Neisseria meningitidis* and *N*.*gonorrhoeae* is made based on [sugar fermentation](\u002Fcarbohydrate-fermentation-test-uses-principle-procedure-results\u002F): **m**eningococci ferment **m**altose whereas **gonococci do not.**\n\n## Complete Comparison: N. gonorrhoeae vs N. meningitidis\n\n| Feature | *N. gonorrhoeae* (Gonococcus) | *N. meningitidis* (Meningococcus) |\n| --- | --- | --- |\n| **Common name** | Gonococcus | Meningococcus |\n| **Gram stain** | Gram-negative diplococcus (kidney\u002Fcoffee-bean shaped) | Gram-negative diplococcus (kidney\u002Fcoffee-bean shaped) |\n| **Capsule** | **Absent** | **Present** — polysaccharide capsule; basis of serogroups and vaccines |\n| **Primary body site** | Urogenital tract, rectum, pharynx, conjunctiva | Nasopharynx (carriage); CNS, blood (disease) |\n| **Transmission** | Sexual contact; maternal–neonatal (birth canal) | Respiratory droplets; close contact |\n| **Carrier state** | No true asymptomatic carriage in genital tract | Nasopharyngeal carriage \\~10% healthy adults |\n| **Key diseases** | Gonorrhoea (urethritis, cervicitis), PID, epididymo-orchitis, ophthalmia neonatorum, DGI | Bacterial meningitis, meningococcaemia, septicaemia, Waterhouse-Friderichsen syndrome |\n| **Glucose fermentation** | **Positive** | **Positive** |\n| **Maltose fermentation** | **Negative** ← key differentiator | **Positive** ← key differentiator |\n| **Lactose fermentation** | Negative | Negative |\n| **Sucrose fermentation** | Negative | Negative |\n| **Oxidase test** | Positive | Positive |\n| **Catalase test** | Positive | Positive |\n| **Colistin sensitivity** | **Sensitive** | **Resistant** (intrinsic resistance — grows on Thayer-Martin containing colistin) |\n| **Serogroups** | None (no capsule) | 13 serogroups; A, B, C, W, X, Y cause >90% of disease |\n| **Vaccine available** | **No** licensed vaccine | **Yes** — MenACWY conjugate; MenB protein-based (Bexsero, Trumenba) |\n| **Primary virulence factor** | Pili (attachment); Opa proteins; IgA protease; Exotoxin A | Polysaccharide capsule (antiphagocytic); LOS; fHbp |\n| **Antibiotic treatment** | Ceftriaxone 500 mg IM single dose (CDC 2020) | Benzylpenicillin IV (empirical); ceftriaxone; rifampicin prophylaxis for contacts |\n| **Penicillin susceptibility** | Historically penicillin; now widespread resistance | Generally penicillin-susceptible (less resistance evolution) |\n| **Lab isolation media** | Modified Thayer-Martin (MTM), NYC medium, chocolate agar | Chocolate agar, blood agar, MTM (for carrier screening) |\n| **Incubation requirements** | 35–37°C, 5–10% CO₂, moist atmosphere | 35–37°C, 5–10% CO₂ |\n| **Oxidase reaction timing** | Positive within 10 seconds | Positive within 10 seconds |\n| **Special culture requirement** | Will not grow on standard agar without enrichment; needs MTM or chocolate agar | Grows on blood and chocolate agar; MTM for clinical specimens with mixed flora |\n| **Specimen types** | Urethral\u002Fcervical swab, rectal swab, pharyngeal swab, conjunctival swab, blood (DGI) | Blood, CSF (meningitis); nasopharyngeal swab (carriage) |\n\n## Laboratory Identification Workflow\n\nWhen oxidase-positive GN diplococci grow on Thayer-Martin or chocolate agar from a clinical specimen, the following workflow distinguishes the two species:\n\n```\nOxidase-positive GN diplococci on MTM\u002Fchocolate agar\n                    ↓\n        Carbohydrate Utilisation Test (CUT)\n        or Rapid CUT (RCUT)\n                    ↓\n    ┌───────────────────────────────────────┐\n    │                                       │\nGlucose +          Glucose +            Glucose +\nMaltose -          Maltose +            Lactose +\n    │                   │                   │\nN. gonorrhoeae     N. meningitidis      N. lactamica\n(genital site)     (any site)           (non-pathogenic)\n```\n\n**The maltose result is definitive.** No other property reliably separates *N. gonorrhoeae* from *N. meningitidis* after Gram stain and oxidase. The colistin resistance property helps explain why both grow on MTM (which contains colistin), but carbohydrate utilisation is the identification standard.\n\n**Additional confirmatory methods:**\n\n- **MALDI-TOF mass spectrometry** — fastest and most accurate; identifies to species level in minutes from a colony; now the gold standard in well-resourced labs\n- **Commercial antigen tests** (e.g., Gonogen, Meritec-GC) — rapid agglutination tests using species-specific antibodies; useful in resource-limited settings\n- **Molecular (NAAT)** — PCR from clinical specimens; does not require viable organisms; highly sensitive and specific; does not require culture\n\n## How to Remember\n\n**The maltose rule — the single most important differentiating test:**\n\n> **M**eningococcus ferments **M**altose **G**onococcus ferments **G**lucose only\n\nOne M matches the other. This is the standard examination question for Neisseria identification and the standard laboratory differentiation test.\n\n**The capsule logic:** Meningococcus HAS a capsule → serogroups → vaccines possible Gonococcus has NO capsule → pili and Opa variation instead → no effective vaccine\n\nThese two facts about the capsule explain: why meningococcal disease can be prevented by vaccination (but gonococcal disease cannot), why meningococcal strains are classified into serogroups (based on capsular polysaccharides) while gonococcal strains are not, and why the two organisms have evolved fundamentally different immune evasion strategies.\n\n**Disease site as a memory anchor:** Meningococcus = **M**eningitis = **M**eninges = CNS Gonococcus = **G**onads = **G**enitourinary tract\n\n**The colistin property explained:** Both organisms grow on Thayer-Martin agar which contains colistin. Meningococci are intrinsically resistant to colistin (LPS modifications). Gonococci are colistin-sensitive but the colistin concentration in MTM is specifically calibrated to suppress other GN bacteria while not inhibiting gonococci — the MTM selectivity exploits concentration, not intrinsic resistance.\n\n**References**\n\n1. Tille, P.M. (2017). *Bailey and Scott's Diagnostic Microbiology* (14th ed.). Elsevier. [Bailey & Scott’s Diagnostic Microbiology](https:\u002F\u002Famzn.to\u002F2WZxPHL). Mosby.\n2. Tinsley, C.R., & Nassif, X. (1996). Analysis of the genetic differences between *N. meningitidis* and *N. gonorrhoeae*. *PNAS*, 93(20), 11109–11114. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1073\u002Fpnas.93.20.11109>\n3. Edwards, J., Quinn, D., Rowbottom, K. A., Whittingham, J. L., Thomson, M. J., & Moir, J. W. (2012). *N. meningitidis* and *N. gonorrhoeae* are differently adapted in the regulation of denitrification. *Biochemical Journal*, 445(1), 69–79. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1042\u002FBJ20111984>\n4. Tzeng, Y.L., & Stephens, D.S. (2000). Epidemiology and pathogenesis of *Neisseria meningitidis*. *Microbes and Infection*, 2(6), 687–700.\n5. Centers for Disease Control and Prevention. (2021). *Sexually Transmitted Infections Treatment Guidelines, 2021: Gonococcal Infections*. MMWR, 70(4).",[],[47],"gram-negative-cocci",[49,57,84,101,110,126,133,151],{"slug":50,"title":51,"description":52,"seoTitle":38,"seoDescription":38,"author":53,"createdDate":54,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":55,"tags":56},"neisseria-meningitidis-properties-pathogenesis-and-laboratory-diagnosis"," Neisseria meningitidis: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria meningitidis causes life-threatening bacterial meningitis and meningococcaemia. Learn its serogroups (A, B, C, W, X, Y), virulence factors (capsule, LOS, fimbriae, IgA protease), clinical features including petechial rash, lab diagnosis (CSF Gram stain, culture, PCR), and vaccines.","Nisha Rijal","2020-07-12",[],[47],{"slug":58,"title":59,"description":60,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":61,"lastUpdatedDate":62,"draft":42,"category":63,"image":38,"faq":64,"tags":83},"rapid-carbohydrate-utilization-test-rcut","RCUT for Neisseria: The Maltose Result That Separates Gonorrhoeae from Meningitidis","Neisseria gonorrhoeae and N. meningitidis look identical under the microscope, but one uses glucose only and the other uses glucose and maltose. RCUT reads that sugar panel in 4 hours, without the false negatives that plagued the old CTA method. Here is the maltose rule, why the test must stay out of a CO2 incubator, and the traps that cause misidentification.","2019-12-11","2026-07-12","biochemical-tests",[65,68,71,74,77,80],{"question":66,"answer":67},"Why is maltose the key sugar in identifying Neisseria?","Because maltose separates the two pathogenic Neisseria that look identical under the microscope. Neisseria gonorrhoeae uses glucose only, while Neisseria meningitidis uses both glucose and maltose. Since glucose is positive for both, it tells you nothing on its own; the maltose result is the discriminator. A memory aid: the M in meningitidis matches the M in maltose. This single result changes the diagnosis from a sexually transmitted infection to a cause of meningitis, along with the treatment and public-health response.",{"question":69,"answer":70},"Why must RCUT not be incubated in a CO2 incubator?","Because dissolved carbon dioxide forms carbonic acid, which turns the phenol red indicator yellow even when the organism has not used any carbohydrate. This produces a false-positive acid reaction in every tube. Although Neisseria are grown in a CO2 atmosphere for primary isolation, the RCUT tubes are incubated in a plain aerobic incubator or water bath at 35 degrees. Grow the organism in CO2, but test it out of CO2.",{"question":72,"answer":73},"Why did RCUT replace the older CTA sugar test?","Because CTA was slow and prone to false negatives. Neisseria produce acid oxidatively rather than fermentatively, so they make very little acid, and the peptone in CTA generates alkaline ammonia that can neutralize that small amount of acid, hiding a true positive. CTA also took 24 to 72 hours. RCUT uses a peptone-free, buffered saline so the weak acid registers, and it gives results in about 4 hours.",{"question":75,"answer":76},"What does it mean if all RCUT sugars stay red?","An organism that produces no acid from any sugar is asaccharolytic. Among the oxidase-positive Gram-negative diplococci, Moraxella catarrhalis is the classic asaccharolytic organism, staying red across glucose, maltose, lactose, and sucrose. It is confirmed with additional tests such as DNase and butyrate esterase. Note that some Neisseria, like N. cinerea, can also appear negative because they over-oxidize the acid to carbon dioxide before it accumulates.",{"question":78,"answer":79},"How is Neisseria lactamica distinguished from Neisseria meningitidis?","By lactose. Both use glucose and maltose, but only Neisseria lactamica also uses lactose, giving a positive lactose result (or a positive ONPG test). N. lactamica is a non-pathogenic commensal of the throat that can otherwise be mistaken for meningococcus, so the lactose or ONPG result is an important safeguard against misidentification.",{"question":81,"answer":82},"Why can contaminated maltose cause a Neisseria misidentification?","Because maltose from some suppliers is contaminated with free glucose. Since Neisseria gonorrhoeae uses glucose, glucose-contaminated maltose can make a gonorrhoeae isolate appear maltose-positive, which would mimic Neisseria meningitidis. Because maltose is the critical result separating those two organisms, this contamination directly causes a wrong identification. Using reagent-grade maltose prevents it.",[47],{"slug":85,"title":86,"description":87,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":88,"lastUpdatedDate":41,"draft":42,"category":89,"image":38,"faq":90,"tags":100},"thayer-martin-agar-composition-preparation-uses-colony-characteristics","Thayer-Martin Agar (Modified): Composition, Principle, Uses, and Colony Characteristics of Neisseria","Modified Thayer-Martin (MTM) agar is the standard selective medium for isolating Neisseria gonorrhoeae from genital specimens. Learn its VCNT antibiotic selectivity, GC agar base composition, colony types, and how it compares to NYC medium and Martin-Lewis agar.","2016-06-13","culture-media",[91,94,97],{"question":92,"answer":93},"Why does Neisseria gonorrhoeae survive colistin in Thayer-Martin agar when most Gram-negative organisms do not?","Colistin (polymyxin E) kills most Gram-negative bacteria by disrupting the outer membrane through binding to lipopolysaccharide (LPS) and displacing calcium and magnesium ions that stabilise the membrane. Neisseria gonorrhoeae has inherent resistance to colistin due to specific modifications in the lipid A component of its LPS — particularly the addition of phosphoethanolamine groups that reduce the net negative charge of the outer membrane surface and decrease colistin binding affinity. These same outer membrane modifications are present in N. meningitidis, explaining why both pathogenic Neisseria species survive in colistin-containing selective media while most other Gram-negative organisms are inhibited.",{"question":95,"answer":96},"What is the significance of T1 and T2 versus T3 and T4 colony types of N. gonorrhoeae, and why does it matter clinically?","N. gonorrhoeae colonies are classified into four types (T1–T4) based on the presence and density of type IV pili on the cell surface. T1 and T2 colonies are small, raised, and glistening — produced by piliated organisms. Pili are major virulence factors that enable the organism to adhere to epithelial cells in the urogenital tract, resist phagocytosis, and initiate infection. T3 and T4 colonies are larger and flatter — produced by non-piliated variants that emerge after repeated subculture in the laboratory. Non-piliated gonococci are avirulent in animal models and cannot efficiently colonise human mucosa. The clinical significance is twofold: (1) fresh clinical isolates should produce T1\u002FT2 colonies, confirming their virulence; and (2) for antibiotic susceptibility testing and research work, only first- or second-passage cultures should be used, because repeated subculture produces T3\u002FT4 non-piliated variants that do not represent the clinical isolate.",{"question":98,"answer":99},"Why must N. gonorrhoeae specimens be inoculated onto Thayer-Martin agar immediately, and what happens if there is a delay?","N. gonorrhoeae has extreme sensitivity to three environmental stresses that make delay fatal: (1) desiccation — the organism dies within minutes on a dry swab due to its lack of protective structures and high membrane permeability; (2) cold temperature — below 35°C, the organism's membrane lipid composition shifts in a way that impairs metabolism and viability; and (3) pH change — metabolic activity of other organisms on the swab produces acid that kills gonococci within hours. In practice, for each hour of delay at room temperature on a plain swab, recovery rates fall significantly. The recommended approach is direct inoculation at the point of collection, with immediate placement into a CO2-enriched environment (CO2 incubator, candle jar, or JEMBEC transport system with CO2-generating tablet). JEMBEC plates — MTM agar in a sealed plastic bag with a CO2-generating sodium bicarbonate tablet — were developed specifically to maintain CO2 levels and temperature during transport, allowing up to 24–48 hour transport with acceptable recovery.",[47],{"slug":102,"title":103,"description":104,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":105,"lastUpdatedDate":106,"draft":42,"category":43,"image":38,"faq":107,"tags":108},"gram-negative-cocci-coccobacilli-medical-significance-list-bacteria-diseases","Gram-Negative Cocci and Coccobacilli of Medical Significance: List, Diseases, and Lab Identification","The medically important Gram-negative cocci include Neisseria gonorrhoeae (gonorrhoea, ophthalmia neonatorum), N. meningitidis (meningitis), and Moraxella catarrhalis (otitis media, COPD). This hub covers all GN cocci and coccobacilli with diseases, key properties, and lab identification links.","2016-04-11","2026-07-18",[],[47,109],"bacterial-classification",{"slug":111,"title":112,"description":113,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":114,"lastUpdatedDate":41,"draft":42,"category":89,"image":38,"faq":115,"tags":125},"new-york-city-medium-agar-introduction-principle-composition-uses","New York City (NYC) Medium: Composition, Principle, Uses, and Colony Characteristics","New York City (NYC) medium is a selective medium for Neisseria gonorrhoeae that uniquely supports genital Mycoplasma and Ureaplasma alongside Neisseria. Learn its principle, horse plasma role, colony characteristics, and how it differs from Modified Thayer-Martin agar.","2014-01-26",[116,119,122],{"question":117,"answer":118},"Why does NYC medium support Mycoplasma and Ureaplasma growth when Modified Thayer-Martin agar does not?","Mycoplasma hominis and Ureaplasma urealyticum are cell wall-deficient organisms with highly reduced genomes that cannot synthesise cholesterol — an essential component of their cell membranes. They must obtain cholesterol from an exogenous source in the culture medium. NYC medium contains horse plasma, which is a rich source of cholesterol and phospholipids that these organisms require for membrane assembly and growth. Modified Thayer-Martin agar uses a haemoglobin supplement and IsoVitaleX growth supplement but contains no plasma, providing no cholesterol source. Additionally, yeast autolysate in NYC medium provides nucleotides and amino acids that support Mycoplasma's limited biosynthetic capacity. The absence of these two components (horse plasma and yeast autolysate) in MTM is why it cannot support Mycoplasma or Ureaplasma growth regardless of the antibiotic composition.",{"question":120,"answer":121},"What is the role of yeast autolysate in NYC medium, and how does it reduce the CO2 requirement?","Yeast autolysate serves two functions in NYC medium. First, it provides a broad range of growth-promoting compounds — vitamins, nucleotides, amino acids, and cofactors — that reduce N. gonorrhoeae's lag phase (the delay before active growth begins), resulting in larger and more numerous colonies compared to media without yeast autolysate. Second, and more distinctively, yeast autolysate contains oxaloacetic acid. N. gonorrhoeae can metabolise oxaloacetate via decarboxylation, producing CO2 as a metabolic byproduct. This endogenous CO2 production partially satisfies the capnophilic requirement of gonococci, reducing (though not eliminating) their dependence on an external CO2 supply. In MTM, no such CO2 self-supply mechanism exists. The practical benefit is that NYC medium produces slightly better colony development in conditions where CO2 supply is inconsistent — relevant in resource-limited settings where CO2 incubators may be unavailable or unreliable.",{"question":123,"answer":124},"How are Mycoplasma hominis and Ureaplasma colonies identified on NYC medium?","Both organisms produce colonies far too small to be seen with the naked eye under normal plate reading conditions. M. hominis produces 'fried-egg' colonies: a dense, granular opaque centre with a flat, transparent peripheral zone spreading around it, typically 200–300 µm in diameter. These require a stereomicroscope or at minimum a hand lens to visualise. U. urealyticum produces even smaller colonies (15–60 µm) that appear dark brown to dark blue-grey and granular under magnification — often described as 'sea-urchin' morphology. To find these colonies on NYC medium after 2–5 days incubation, hold the plate under oblique lighting and scan the area between the visible N. gonorrhoeae colonies systematically under magnification. A useful rapid presumptive test is the urease test: U. urealyticum is strongly urease-positive — applying urease reagent to suspect colonies produces a colour change confirming ureaplasma activity.",[47],{"slug":127,"title":128,"description":129,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":130,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":131,"tags":132},"neisseria-gonorrhoeae-properties-disease-pathogenesis-and-laboratory-diagnosis","Neisseria gonorrhoeae: Properties, Pathogenesis, Virulence Factors, and Lab Diagnosis","Neisseria gonorrhoeae causes gonorrhoea — the second most common STI globally. Learn its Gram-negative diplococcus properties, virulence factors (pili, Opa proteins, IgA protease, LOS, PorB), diseases (urethritis, PID, ophthalmia neonatorum), lab diagnosis (Gram stain, culture, NAAT), and AMR resistance timeline.","2013-06-10",[],[47],{"slug":134,"title":135,"description":136,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":137,"lastUpdatedDate":138,"draft":42,"category":43,"image":38,"faq":139,"tags":149},"fluorescent-treponemal-antibody-absorption-fta-abs-test","FTA-ABS Test: Interpretation, When It Confirms Syphilis, and FTA-ABS vs TPPA","How to interpret an FTA-ABS result: what reactive-plus-reactive-RPR confirms, why FTA-ABS stays positive for life, why it cannot monitor treatment, and how it now compares to TPPA in modern syphilis testing.","2013-06-03","2026-07-20",[140,143,146],{"question":141,"answer":142},"Why does the FTA-ABS test remain positive for life after treated syphilis, and what are the implications?","The FTA-ABS detects IgG antibodies directed specifically against Treponema pallidum antigens. Once the immune system has generated these antibodies in response to a treponemal infection, immunological memory B cells persist indefinitely and continue producing low levels of anti-treponemal IgG even after the infection has been eradicated by antibiotics. Antibiotic treatment kills the bacteria and stops the stimulus for new antibody production, but it cannot eliminate existing long-lived plasma cells or memory B cells that were generated during the infection. As a result, anti-treponemal antibody titers decline slowly but rarely reach undetectable levels — most treated patients remain FTA-ABS reactive for years to decades, and many remain positive for life. The clinical implication is that FTA-ABS cannot be used to confirm cure or active infection in a previously treated patient: a reactive FTA-ABS in someone with a history of treated syphilis five years ago simply confirms past infection. Only non-treponemal tests (RPR, VDRL) with their declining titers post-treatment can monitor treatment response and distinguish active from past infection.",{"question":144,"answer":145},"What is the significance of a beaded or atypical fluorescence pattern on FTA-ABS?","A beaded or atypical fluorescence pattern on FTA-ABS, where discrete fluorescent beads appear along the length of the treponemes rather than the uniform homogeneous fluorescence seen in true positive results, is associated with systemic lupus erythematosus (SLE). In SLE patients, auto-antibodies — particularly anti-DNA and anti-nuclear antibodies — can cross-react with treponeme antigens non-specifically, producing fluorescence that follows the outline of the organism but with an irregular, beaded appearance rather than the smooth, bright green fluorescence of a true positive. This atypical beaded pattern on FTA-ABS in a patient with known SLE or strong clinical features of autoimmune disease should be interpreted as a false positive rather than evidence of syphilis. Confirmation with an alternative treponemal test (TPHA or TPPA) and correlation with clinical findings, risk factors for syphilis, and RPR\u002FVDRL results is essential before making a syphilis diagnosis in this context.",{"question":147,"answer":148},"Why is FTA-ABS considered more sensitive than TPHA in early primary syphilis?","In the first 3–4 weeks after T. pallidum infection, the immune response is still developing and antibody concentrations are low. Both FTA-ABS and TPHA detect treponemal antibodies, but they differ in their detection mechanisms and sensitivity thresholds at this early stage. FTA-ABS uses fluorescence microscopy to directly visualise antibody coating on individual T. pallidum organisms — even small amounts of antibody produce detectable fluorescence on the treponemes. TPHA requires antibodies to agglutinate T. pallidum-sensitised red blood cells — a threshold event that requires somewhat higher antibody concentrations to produce visible agglutination. Because FTA-ABS can detect treponemal antibodies at slightly lower concentrations than TPHA, it becomes positive 1–2 weeks earlier in the primary stage, when antibodies are just beginning to appear. In established primary syphilis with a visible chancre, FTA-ABS has approximately 85–90% sensitivity compared to TPHA's 65–76% — a meaningful difference that makes FTA-ABS the preferred test when primary syphilis is strongly suspected and TPHA is negative.",[47,150],"immunofluorescence",{"slug":152,"title":153,"description":153,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":137,"lastUpdatedDate":154,"draft":42,"category":43,"image":38,"faq":155,"tags":156},"venereal-disease-research-laboratory-vdrl-test","VDRL Test: Principle, Procedure, Results","2026-07-05",[],[47],[158,164,171,176,180,184,189,194,198,202],{"slug":159,"name":39,"description":160,"image":161,"body":162,"postCount":163},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":165,"name":166,"description":167,"image":168,"body":169,"postCount":170},"ashma-shrestha","Ashma Shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":172,"name":173,"description":174,"image":38,"body":38,"postCount":175},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":177,"name":178,"description":174,"image":38,"body":38,"postCount":179},"samikshya-acharya","Samikshya Acharya",20,{"slug":181,"name":182,"description":174,"image":38,"body":38,"postCount":183},"alisha-tripathi","Alisha Tripathi",6,{"slug":185,"name":186,"description":187,"image":38,"body":38,"postCount":188},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",9,{"slug":190,"name":191,"description":192,"image":38,"body":38,"postCount":193},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":195,"name":196,"description":174,"image":38,"body":38,"postCount":197},"srijana-khanal","Srijana Khanal",18,{"slug":199,"name":200,"description":192,"image":38,"body":38,"postCount":201},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":203,"name":53,"description":174,"image":38,"body":204,"postCount":205},"nisha-rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]